Pathogenesis of myeloma bone disease
Top Cited Papers
- 27 November 2008
- journal article
- review article
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 23 (3), 435-441
- https://doi.org/10.1038/leu.2008.336
Abstract
Bone disease in multiple myeloma (MM) is characterized by lytic bone lesions, which can cause severe bone pain, pathologic fractures and hypercalcemia. However, the lytic bone disease in MM differs from that in other cancer patients who have lytic bone metastases. Although increased osteoclastic bone destruction is involved in MM and other tumors involving bone, in contrast to other tumors, once the MM tumor burden exceeds 50% in a local area, osteoblast activity is either suppressed or absent.1 The basis for this severe imbalance between increased osteoclastic bone resorption and decreased bone formation has been a topic of intensive investigation over the last several years and will be reviewed in this article.Keywords
This publication has 75 references indexed in Scilit:
- HSP70 inhibition reverses cell adhesion mediated and acquired drug resistance in multiple myelomaBritish Journal of Haematology, 2008
- The pathogenesis of the bone disease of multiple myelomaBone, 2008
- Pathologic fractures correlate with reduced survival in patients with malignant bone diseaseCancer, 2007
- Fracture Risk With Multiple Myeloma: A Population-Based StudyJournal of Bone and Mineral Research, 2005
- Osteoclasts enhance myeloma cell growth and survival via cell-cell contact: a vicious cycle between bone destruction and myeloma expansionBlood, 2004
- Involvement of Notch-1 signaling in bone marrow stroma-mediated de novo drug resistance of myeloma and other malignant lymphoid cell linesBlood, 2004
- Pathogenesis of myeloma bone diseaseBlood Cells, Molecules, and Diseases, 2004
- Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Myeloma Aredia Study Group.Journal of Clinical Oncology, 1998
- Biochemical, histomorphometric and densitometric changes in patients with multiple myeloma: effects of glucocorticoid therapy and disease activityBritish Journal of Haematology, 1997
- Abnormal bone remodelling in patients with myelomatosis and normal biochemical indices of bone resorptionEuropean Journal of Haematology, 1992